valgansiklovir

Valganciclovir hydrochloride () is the prodrug of ganciclovir and is rapidly converted into ganciclovir after oral administration. Valganciclovir hydrochloride (trade name Valganciclovir, etc.) is an antiviral drug used to treat patients with acquired immunodeficiency syndrome (AIDS) combined with cytomegalovirus (CMV) retinitis, and to prevent CMV infection in high-risk solid organ transplant patients. Valganciclovir needs to be taken long-term because Valganciclovir only suppresses, not cures, the infection.

Cytomegalovirus infection is a common complication after organ transplantation, with an incidence rate as high as 50%. The pain caused by organ rejection, cardiovascular disease, post-transplantation diabetes and related treatments has seriously affected the quality of life of patients. Valganciclovir Hydrochloride Tablets (Valgansiklovir) is an oral anti-cytomegalovirus infection drug that combines the advantages of oral administration and intravenous injection. Just taking 2 tablets of Valganciclovir Hydrochloride (Valgansiklovir) every day can effectively prevent and treat CMV infection, avoid the direct and indirect harm caused by CMV infection, and significantly improve the patient's quality of life and long-term survival rate.

It is understood that there is no generic version of Valganciclovir hydrochloride, only the original version. Valganciclovir hydrochloride (Valganciclovir) is marketed in China in specifications of 450mg-60 tablets/bottle, priced at $16,500. In major countries around the world, the price is more than $10,000, which is a burden for patients. The price of Valganciclovir Hydrochloride Tablets () in India on "World Pharmacy" is the lowest in the world, equivalent to only 5,500$ in RMB.